Track topics on Twitter Track topics that are important to you
LAS VEGAS, NV -- (Marketwired) -- 06/08/15 -- RAMOIL MANAGEMENT, Ltd. (OTC PINK: RAMO) announced today that they have secured a new partnership agreement. RAMO recently finalized a funding and distribution deal with United Enterprises that is integral to the company's ability to sustain long term growth and forecasts the generation of significant near-term revenues.
Company executives have been working diligently to finalize details of the agreement and are excited to announce this new deal. Tim Stokes, CEO of Ramoil Management, Ltd. said, "We are delivering on every pledge we've made to our shareholders and United Enterprises is a big part of that promise," he added, "UE (United Enterprises) is securing our ability to build on our partnership with (organizations like) Nature Elements and this deal will help generate revenues well into the six figures in the near term." United Enterprises is providing funding for CBD extraction equipment and will assist with the distribution of RAMO hydroponic products.
Stokes also commented on future partnerships mentioned in previous shareholder updates. "Today's announcement is a major step on our road to profitability. There are several partnership and consulting agreements we are working on that will allow us to scale our business exponentially." Stokes also alluded to the fact that this new agreement will significantly strengthen existing partnerships and will allow the company greater financial flexibility.
About Ramoil Management, Ltd. Ramoil Management, Ltd. (RAMO) is a development stage company focused on the operations of licensed and legal cultivation, extraction, manufacturing and retail facilities. The company's evolving business plan establishes domestic and international research and production laboratories working to perfect a proprietary strain of high CBD/low THC extraction compounds. The company plan focuses on revenues generated from the delivery of CBD extractions, concentrates and medicines using established wholesale and retail partnerships.
Forward Looking Statements: This news release contains forward-looking statements made by RAMOIL MANAGEMENT, LTD. All such statements included in this press release, other than statements of historical fact, are forward-looking statements. Although management believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to have been correct. Actual results may differ materially from those indicated by these statements. The following risk factors, among others, could cause actual results to differ materially from those described in any forward- looking statements. These risks and uncertainties include, but are not limited to, economic conditions, changes in the law or regulations, demand for products of the Company, the effects of competition and other factors that could cause actual results to differ materially from those projected or represented in the forward looking statements. Forward-looking statements are typically identified by the words: believe, expect, anticipate, intend, estimate, and similar expressions or which by their nature refer to future events. The Company is not entitled to rely on the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 because it is not registered under either Act.Timothy Stokes Interim President and CEO 1-702-381-1961 NEXT ARTICLE
Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...
Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.